Ridgeback Discloses 7.6% Stake in Replimune
Replimune Group, Inc. Schedule 13G reports that Ridgeback entities beneficially own 6,252,651 shares of common stock, representing 7.6% of the class based on January 30, 2026 outstanding share count.
Rhea-AI Filing Summary
Replimune Group, Inc. Schedule 13G reports that Ridgeback entities beneficially own 6,252,651 shares of common stock, representing 7.6% of the class based on January 30, 2026 outstanding share count. The reporting group is Ridgeback Capital Investments L.P., Ridgeback Capital Investments LLC, and Ridgeback Capital Management LLC.
The filing states that the shared voting and dispositive power over these shares is 6,252,651 and that RCI and RCM may be deemed to beneficially own all shares by Rule 13d-3; each disclaims ownership except to the extent of any pecuniary interest. Signatures by counsel are dated 05/21/2026.
Positive
- None.
Negative
- None.
Insights
Ridgeback discloses a passive beneficial stake of 7.6%.
The filing lists 6,252,651 shares as beneficially owned by the Ridgeback entities and ties the ownership percentage to an outstanding share base of 82,572,619 shares as of January 30, 2026. The statement follows Schedule 13G format, which typically indicates passive or passive/qualified investor status rather than an active Section 13(d) seeking control.
Watch for future amendments if voting or acquisition intent changes, since Schedule 13G holdings can convert to Schedule 13D disclosures upon active acquisition intent; timing or intent is not stated in this excerpt.
Disclosure clarifies who holds shared voting and dispositive power within the Ridgeback group.
The filing explains that RCI is the general partner of RCILP and that RCM maintains investment and voting power under an investment management agreement, with Wayne Holman controlling RCM. Each entity lists 0 sole power and 6,252,651 shared power to vote and dispose.
For stakeholder communications, subsequent filings or company statements would be the source of any change to these arrangements; the excerpt includes a joint filing agreement as Exhibit 99.1 and counsel signatures dated 05/21/2026.
Key Figures
Key Terms
Schedule 13G regulatory
beneficially own financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Ridgeback hold in Replimune (REPL)?
Which Ridgeback entities are listed as reporting owners?
Does the Schedule 13G indicate sole voting control by Ridgeback?
Who controls Ridgeback’s investment authority noted in the filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.